These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7585146)

  • 1. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.
    Tiihonen J; Kuikka J; Bergström K; Hakola P; Karhu J; Ryynänen OP; Föhr J
    Nat Med; 1995 Jul; 1(7):654-7. PubMed ID: 7585146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour.
    Tiihonen J; Kuikka JT; Bergström KA; Karhu J; Viinamäki H; Lehtonen J; Hallikainen T; Yang J; Hakola P
    Eur J Nucl Med; 1997 Oct; 24(10):1253-60. PubMed ID: 9323266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis.
    Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Räsänen P; Eronen M
    Neurosci Lett; 1998 Sep; 253(3):195-7. PubMed ID: 9792244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporters increase in human brain after alcohol withdrawal.
    Laine TP; Ahonen A; Torniainen P; Heikkilä J; Pyhtinen J; Räsänen P; Niemelä O; Hillbom M
    Mol Psychiatry; 1999 Mar; 4(2):189-91, 104-5. PubMed ID: 10208452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.
    Tiihonen J; Vilkman H; Räsänen P; Ryynänen OP; Hakko H; Bergman J; Hämäläinen T; Laakso A; Haaparanta-Solin M; Solin O; Kuoppamäki M; Syvälahti E; Hietala J
    Mol Psychiatry; 1998 Mar; 3(2):156-61. PubMed ID: 9577840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter and D2-receptor density in late-onset alcoholism.
    Repo E; Kuikka JT; Bergström KA; Karhu J; Hiltunen J; Tiihonen J
    Psychopharmacology (Berl); 1999 Dec; 147(3):314-8. PubMed ID: 10639691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics.
    Laine TP; Ahonen A; Räsänen P; Pohjalainen T; Tiihonen J; Hietala J
    Alcohol Alcohol; 2001; 36(3):262-5. PubMed ID: 11373265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
    Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
    Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter density and novelty seeking among alcoholics.
    Laine TP; Ahonen A; Räsänen P; Tiihonen J
    J Addict Dis; 2001; 20(4):91-6. PubMed ID: 11760929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractal analysis of striatal dopamine re-uptake sites.
    Kuikka JT; Tiihonen J; Karhu J; Bergström KA; Räsänen P
    Eur J Nucl Med; 1997 Sep; 24(9):1085-90. PubMed ID: 9283099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
    Tissingh G; Bergmans P; Booij J; Winogrodzka A; van Royen EA; Stoof JC; Wolters EC
    J Neurol; 1998 Jan; 245(1):14-20. PubMed ID: 9457623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in dopamine receptors but not in dopamine transporters in alcoholics.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype influences in vivo dopamine transporter availability in human striatum.
    Heinz A; Goldman D; Jones DW; Palmour R; Hommer D; Gorey JG; Lee KS; Linnoila M; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):133-9. PubMed ID: 10649826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage.
    Heinz A; Saunders RC; Kolachana BS; Jones DW; Gorey JG; Bachevalier J; Weinberger DR
    Synapse; 1999 May; 32(2):71-9. PubMed ID: 10231127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
    Innis RB; Seibyl JP; Scanley BE; Laruelle M; Abi-Dargham A; Wallace E; Baldwin RM; Zea-Ponce Y; Zoghbi S; Wang S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11965-9. PubMed ID: 8265656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.